People

Andrew Wiemer, Ph.D.

photo of andrew wiemer

Dr. Wiemer is an Associate Professor in the Department of Pharmaceutical Sciences at the University of Connecticut. He is also affiliated with the Institute for Systems Genomics. Dr. Wiemer received a B.S. in Biology from the University of Notre Dame. He earned a Ph.D. in Molecular & Cellular Biology from the University of Iowa, where he developed inhibitors of geranylgeranyl diphosphate synthase. He performed a postdoctoral research at the University of Wisconsin-Madison, studying T cell adhesion and migration. He has received research support from the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Institute on Aging, the American Cancer Society, the American Association of Colleges of Pharmacy, and the Frasch Foundation for Chemical Research. He is a member of the American Chemical Society, the American Association of Immunologists, the American Society for Pharmacology and Experimental Therapeutics, the American Society for Biochemistry and Molecular Biology, and the American Association of Colleges of Pharmacy. Dr. Wiemer has served as a grant reviewer for the United States National Institutes of Health, the United States National Science Foundation, the United States Department of Defense, the Israel Ministry of Science, Technology and Space, and the French National Research Agency.

Megan Schladetsch, B.S.

Megan Schladetsch

Megan Schladetsch is a Pharmaceutical Sciences Ph.D. student in the Wiemer lab studying Medicinal Chemistry. She received her B.S. in Biochemistry from the University of Portland in Oregon. Megan’s research currently focuses on testing inhibitors of isoprenoid biosynthesis and their potential effects in the human mevalonate pathway and immunity.

Xueting Huang, B.S.

Xueting Huang

Xueting Huang is a Pharmaceutical Sciences Ph.D. student in Dr. Wiemer’s lab studying Medicinal Chemistry. She received her B.S. in Pharmaceutical Engineering from China Pharmaceutical University, where she was involved in the research on anticancer peptides. Xueting’s research currently focuses on drug discovery in cancer immunology.

Yiming Jin, B.S., M.M.

Yiming Jin is a Pharmaceutical Sciences Ph.D. student in Dr. Wiemer’s lab studying Medicinal Chemistry. He received his M.M. and B.S. from the Pharmacy School of Shandong University, where he was involved in research on chemical synthesis, nanomaterials, polysaccharide immunological activities and tumor vaccines.

Michael Poe, Ph.D.

Photo of Mike Poe

Michael Poe is a postdoctoral fellow in Dr. Wiemer’s lab. He received his B.S. in Chemistry from the University of Minnesota-Duluth and his Ph.D. in Organic Chemistry from the University of Wisconsin-Milwaukee, where he synthesized novel GABA agonists. Mike’s research focuses on synthesis and evaluation of novel butyrophilin agonists.

Rohit Singh, Ph.D.

Photo of Rohit Singh

Rohit Singh is a postdoctoral research associate in Dr. Wiemer’s lab. He received his B. Pharmacy and M. Pharmacy from the RGPV, Bhopal and completed his Ph.D. in Chemical Sciences from CSIR-IIIM, Jammu, where he focused on synthetic modifications of anti-inflammatory natural products.  Rohit’s research focuses on synthesis and evaluation of novel phosphoantigens.

Avi Mahajan

Avi Mahajan

Avi Mahajan is an undergraduate student in Dr. Wiemer’s lab, majoring in Molecular and Cell Biology. His research is focused on novel peptides and their effectiveness in immune co-receptor targeting.

Reinier González

Reinier Gonzalez

Reinier González is an undergraduate student working in Dr. Wiemer’s Lab. He is currently pursuing a degree in Molecular and Cell Biology. Reinier’s research focuses on directional cloning to uncover potential immunotherapy ligands.

Anthony Zhang

Anthony Zhang is a Molecular and Cell Biology undergraduate student in Dr. Wiemer’s lab. His research focuses on immune checkpoint proteins and how they can be targeted for cancer therapy.

Benson Shi

Benson Shi is an undergraduate researcher in Dr. Wiemer’s lab, majoring in Molecular and Cell Biology. His research focuses on immune checkpoint proteins.

Sarah San Vicente

Sarah San Vicente is an undergraduate student working in Dr. Wiemer’s lab, majoring in Molecular and Cell Biology. Her research focuses on the interconnected roles of immunotherapy and radiotherapy in novel cancer therapeutics.

Alumni

Jin Li, Ph.D.

Photo of Jin Li

Jin Li received her Ph.D. in Medicinal Chemistry from the University of Connecticut in 2019. Jin’s research focused on the discovery of novel therapeutics and immunotherapeutics for malignant tumors. She is currently a postdoctoral fellow at the University of Connecticut. 

Sherry Agabiti, Ph.D.

Photo of Sherry Su

Sherry Agabiti received her Ph.D. in Medicinal Chemistry from the University of Connecticut in 2018. Sherry’s research focused on identifying novel compounds for cancer therapy, and investigating the roles of such compounds in cancer cell adhesion, motility, and proliferation. She is currently a postdoctoral fellow at Yale University. 

Ashley Kilcollins, Ph.D.

Photo of Ashley Kilcollins

Ashley Kilcollins received her Ph.D. in Physiology & Neurobiology from the University of Connecticut in 2017. Ashley’s thesis focused on the mechanisms of action of phosphoantigen prodrugs. She performed postdoctoral research at Weill Cornell Medical School.

Brendan Zangari, B.S.

Brendan Zangari received his B.S. in Molecular and Cell Biology from the University of Connecticut. Brendan’s research focused on the structure activity relationships of phosphoantigen prodrugs. He is currently a graduate student in immunology at Roswell Park.

Victoria Li, B.S.

Photo of Victoria Li

Victoria Li received a B.S. in Biological Sciences from the University of Connecticut. Victoria’s research focused on stimulation of γδ T cells with natural and synthetic compounds.

Prabhath Mannam, B.S.

Prabhath Mannam

Prabhath Mannam received a dual degree in Molecular and Cell Biology and Physiology & Neurobiology from the University of Connecticut. Prabhath’s research focused on directional cloning to identify novel immunotherapy ligands.

Drew Gazetos, Pharm.D.

Drew Gazetos

Drew Gazetos received his Pharm.D. from the University of Connecticut. Drew’s research focused on kinase inhibitors and their effect on T cell activation.

MinJi Choi, Pharm.D.

MinJi Choi

MinJi Choi received her Pharm.D. from the University of Connecticut. MinJi’s research focused on immune checkpoints and their effect on T cell activation.

Caroline Liu, B.S.

Caroline Liu

Caroline Liu received her B.S. in Molecular and Cell Biology from the University of Connecticut. Caroline’s research focused on site-directed mutagenesis of immune receptors and effects on ligand binding.

Willie Dong, B.S.

Willie Dong received his B.S. in Physiology & Neurobiology at the University of Connecticut. Willie’s research focused on response of leukemia cells to treatment with experimental chemotherapy agents. Willie is currently a medical student at the University of Vermont.

Andrew Hederman, B.S.

Andrew Hederman received his B.S. in Biomedical Engineering from the University of Connecticut. Andrew’s research focused on using flow cytometry to assess T cell proliferation. He is currently a senior research associate in T cell biology at Kite Pharma.

Chris Jensen, Pharm.D.

Chris Jensen received his Pharm.D. from the University of Connecticut. Chris’s research focused on proliferation of leukemia cells in response to inhibitors of isoprenoid biosynthesis. He is currently Associate Director of Medical Affairs at Biohaven Pharmaceuticals.